Back to Newsroom

Strand Life Sciences Introduces Scientific Advisory Board

AURORA, Colo., May 13, 2015 – Strand Life Sciences, a global genomic profiling company that uses next-generation sequencing technology to empower cancer care, today announced the appointment of its scientific advisory board.

“Our scientific advisory board members are thought-leaders in genetics and molecular biology who will help guide the work of the more than 200 scientists and engineers we employ to advance our pan-cancer genomic profiling technology,” said Scott Storrer, global president of Strand Life Sciences. “The board’s expertise will be invaluable as we continue to enhance StrandAdvantage to enable faster, cheaper and better precision medicine.”

Click here to read more